Precision BioSciences shows muscle improvements in DMD gene therapy study

Go back to Precision BioSciences shows muscle improvements in DMD gene therapy study
(NASDAQ: DTIL) Delayed: 8.13 -0.11 (1.33%)
Previous Close $8.24    52 Week High
Open $8.24    52 Week Low
Day High $8.30    P/E N/A 
Day Low $8.07    EPS
Volume 8,799